Caxton Corp has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $4.59 Million distributed in 12 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rezolute, Inc. with a value of $3.83M, Spdr Gold Trust with a value of $374K, Berkshire Hathaway Inc Class B with a value of $248K, Compass Therapeutics, Inc. with a value of $82K, and Cardiff Oncology, Inc. with a value of $41K.

Examining the 13F form we can see an decrease of $11.2M in the current position value, from $15.8M to 4.59M.

Caxton Corp is based out at Princeton, NJ

Below you can find more details about Caxton Corp portfolio as well as his latest detailed transactions.

Portfolio value $4.59 Million
Healthcare: $3.97 Million
ETFs: $374,000
Financial Services: $248,000

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 12
  • Current Value $4.59 Million
  • Prior Value $15.8 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Caxton Corp Portfolio

Follow Caxton Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Corp with notifications on news.